{"first_name":"Kevin","last_name":"Forrest","permalink":"kevin-forrest","crunchbase_url":"http://www.crunchbase.com/person/kevin-forrest","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Mon Jun 08 09:24:59 UTC 2009","updated_at":"Mon Jun 08 09:27:01 UTC 2009","overview":"<p>Kevin M. Forrest, Ph.D. joined 5AM Ventures in 2005 from Princeton University where he studied RNA-based regulatory processes. His work has been published in Current Biology, Development, and Developmental Cell. Prior to Princeton, Dr. Forrest was a summer fellow at the National Institutes of Health where he studied the genetics of human stuttering. Dr. Forrest previously served as a due diligence advisor to ProQuest Investments. Dr. Forrest currently represents 5AM as a Board Observer to Flexion, Marcadia, Relypsa, Synosia and Variation. Dr. Forrest holds a B.S. in Biology from Boston College and a Ph.D. in Molecular Biology from Princeton University. Dr. Forrest is based in the Waltham, MA office.</p>","image":{"available_sizes":[[[145,150],"assets/images/resized/0004/7318/47318v1-max-150x150.jpg"],[[155,160],"assets/images/resized/0004/7318/47318v1-max-250x250.jpg"],[[155,160],"assets/images/resized/0004/7318/47318v1-max-450x450.jpg"]],"attribution":""},"degrees":[],"relationships":[{"is_past":false,"title":"Principal","firm":{"name":"5AM Ventures","permalink":"5am-ventures","type_of_entity":"financial_org","image":{"available_sizes":[[[149,105],"assets/images/resized/0004/7316/47316v1-max-150x150.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-250x250.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}